Strata Skin Sciences PE Ratio 2010-2025 | SSKN

Current and historical p/e ratio for Strata Skin Sciences (SSKN) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Strata Skin Sciences PE ratio as of June 19, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Strata Skin Sciences PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-06-18 2.36 0.00
2025-03-31 2.64 $-2.27 0.00
2024-12-31 2.91 $-2.69 0.00
2024-09-30 2.75 $-2.66 0.00
2024-06-30 3.07 $-2.43 0.00
2024-03-31 3.78 $-3.30 0.00
2023-12-31 5.50 $-3.10 0.00
2023-09-30 5.95 $-2.00 0.00
2023-06-30 9.50 $-2.00 0.00
2023-03-31 10.59 $-1.60 0.00
2022-12-31 7.90 $-1.50 0.00
2022-09-30 8.71 $-1.70 0.00
2022-06-30 9.61 $-1.60 0.00
2022-03-31 14.70 $-0.80 0.00
2021-12-31 14.65 $-0.80 0.00
2021-09-30 18.40 $-0.70 0.00
2021-06-30 15.60 $-0.90 0.00
2021-03-31 16.70 $-1.70 0.00
2020-12-31 15.00 $-1.30 0.00
2020-09-30 13.50 $-1.40 0.00
2020-06-30 11.50 $-1.30 0.00
2020-03-31 9.50 $-0.80 0.00
2019-12-31 20.80 $-0.50 0.00
2019-09-30 21.50 $-0.30 0.00
2019-06-30 24.90 $-0.10 0.00
2019-03-31 28.50 $-0.70 0.00
2018-12-31 26.00 $-2.00 0.00
2018-09-30 35.40 $-3.00 0.00
2018-06-30 20.50 $-58.10 0.00
2018-03-31 11.70 $-62.70 0.00
2017-12-31 12.30 $-71.70 0.00
2017-09-30 17.70 $-75.20 0.00
2017-06-30 24.30 $-27.00 0.00
2017-03-31 30.25 $-33.30 0.00
2016-12-31 22.00 $-36.00 0.00
2016-09-30 26.50 $-34.50 0.00
2016-06-30 30.50 $-92.00 0.00
2016-03-31 47.25 $-129.00 0.00
2015-12-31 55.50 $-172.00 0.00
2015-09-30 57.00 $-226.00 0.00
2015-06-30 57.50 $-183.50 0.00
2015-03-31 128.50 $-129.00 0.00
2014-12-31 60.00 $-153.00 0.00
2014-09-30 86.00 $-141.00 0.00
2014-06-30 160.60 $-204.00 0.00
2014-03-31 311.50 $-295.00 0.00
2013-12-31 320.00 $-300.00 0.00
2013-09-30 365.00 $-350.00 0.00
2013-06-30 465.00 $-350.00 0.00
2013-03-31 580.00 $-355.00 0.00
2012-12-31 895.00 $-365.00 0.00
2012-09-30 1605.00 $-375.00 0.00
2012-06-30 1630.00 $-410.00 0.00
2012-03-31 2240.00 $-415.00 0.00
2011-12-31 1845.00 $-420.00 0.00
2011-09-30 2215.00 $-420.00 0.00
2011-06-30 1170.00 $-400.00 0.00
2011-03-31 1760.00 $-405.00 0.00
2010-12-31 1675.00 $-415.00 0.00
2010-09-30 3260.00 $-435.00 0.00
2010-06-30 3720.00 $-465.00 0.00
2010-03-31 3710.00 $-475.00 0.00
2009-12-31 5155.00 $-480.00 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.010B $0.034B
Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.989B 58.51
Hims & Hers Health (HIMS) United States $13.669B 142.02
Tempus AI (TEM) United States $11.962B 0.00
IRhythm Technologies (IRTC) United States $4.646B 0.00
Inspire Medical Systems (INSP) United States $3.825B 59.77
Hinge Health (HNGE) United States $3.100B 0.00
Privia Health (PRVA) United States $2.659B 181.75
Enovis (ENOV) United States $1.751B 9.76
Schrodinger (SDGR) United States $1.545B 0.00
Phreesia (PHR) United States $1.527B 0.00
Clover Health Investments (CLOV) United States $1.511B 0.00
Azenta (AZTA) United States $1.371B 63.70
10x Genomics (TXG) United States $1.338B 0.00
Omnicell (OMCL) United States $1.324B 23.36
Claritev (CTEV) United States $0.663B 0.00
Fulgent Genetics (FLGT) United States $0.618B 0.00
Butterfly Network (BFLY) United States $0.534B 0.00
Veradigm (MDRX) United States $0.482B 0.00
Talkspace (TALK) United States $0.463B 138.50
Standard BioTools (LAB) United States $0.414B 0.00
Outset Medical (OM) United States $0.347B 0.00
TruBridge (TBRG) United States $0.346B 766.67
Nyxoah SA (NYXH) Belgium $0.263B 0.00
Health Catalyst (HCAT) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.150B 0.00
EUDA Health Holdings (EUDA) Singapore $0.139B 0.00
Pulmonx (LUNG) United States $0.111B 0.00
CareCloud (CCLD) United States $0.107B 4.06
American Well (AMWL) United States $0.106B 0.00
MDxHealth SA (MDXH) Belgium $0.096B 0.00
111 (YI) China $0.068B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.046B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Zhongchao (ZCMD) China $0.031B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00